For the Inventor, By the Inventor

Enter assignee name

Malvern, PA, United States of America

Venatorx Pharmaceuticals, Inc.

USPTO Granted Patents = 38

CIPO Patents = 1

EPO Patents = 10

Trademarks = 2

Forward Citations = 313

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Christopher J Burns (36 out of 51 patents)

Bin Liu (26 out of 29 patents)

Daniel C Pevear (26 out of 37 patents)

4. Denis Daigle (25 out of 25 patents)

5. Daniel McGarry (25 out of 25 patents)

6. Robert E Lee Trout (23 out of 23 patents)

7. Steven Armen Boyd (13 out of 51 patents)

8. Randy W Jackson (12 out of 12 patents)

9. Stephen M Condon (9 out of 36 patents)

10. Jodie Hamrick (9 out of 9 patents)

11. Jiangchao Yao (7 out of 50 patents)

12. Glen Coburn (6 out of 6 patents)

13. Guo-Hua Chu (6 out of 12 patents)

14. Eugen F Mesaros (4 out of 13 patents)

15. Christopher Benetatos (4 out of 4 patents)

38 patents: Sort by Forward Citations

1. 12187752 - Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof (2025-01-07),

2. 12173018 - Penicillin-binding protein inhibitors (2024-12-24),

3. 12102648 - Orally-bioavailable nucleoside analogs (2024-10-01),

4. 12084445 - Broad-spectrum carbapenems (2024-09-10),

5. 11820784 - Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof (2023-11-21),

6. 11638715 - Orally-bioavailable nucleoside analogs (2023-05-02),

7. 11566001 - Hepatitis B capsid assembly modulators (2023-01-31),

8. 11560392 - Boron-containing compounds (2023-01-24),

9. 11414435 - Beta-lactamase inhibitors (2022-08-16),

10. 11332485 - Penicillin-binding protein inhibitors (2022-05-17),

11. 11267826 - Penicillin-binding protein inhibitors (2022-03-08),

12. 11247965 - Hepatitis B capsid assembly modulators (2022-02-15),

13. 11091505 - Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof (2021-08-17),

14. 11046716 - Beta-lactamase inhibitors (2021-06-29),

15. 11014881 - Hepatitis B capsid assembly modulators (2021-05-25),

Venatorx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel multi-targeting anti-infective therapeutics to address the increasing threat of antibiotic resistance. With expertise in medicinal chemistry and clinical development, Venatorx aims to advance innovative drugs that combat serious bacterial infections caused by drug-resistant pathogens.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

38 Patents

#17 in Malvern, PA

#331 in Pennsylvania

#8,725 in US

#17,311 in the World

Malvern, PA, United States of America

Venatorx Pharmaceuticals, Inc.

Forward Citations = 313

31 inventors:

Christopher J Burns (36 out of 51 patents)

Bin Liu (26 out of 29 patents)

Daniel C Pevear (26 out of 37 patents)

4. Denis Daigle (25 out of 25 patents)

5. Daniel McGarry (25 out of 25 patents)

Please report any incorrect information to support@idiyas.com

Loading…